NervGen Pharma Corp. (NGENF)
OTCMKTS · Delayed Price · Currency is USD
2.460
-0.029 (-1.17%)
Aug 1, 2025, 3:59 PM EDT
Smartsheet Market Cap
NervGen Pharma has a market cap or net worth of $179.58 million as of August 1, 2025. Its market cap has increased by 20.15% in one year.
Market Cap
179.58M
Enterprise Value
169.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.46
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 37.55M to 179.58M, an increase of 378.26%. That is a compound annual growth rate of 27.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 182.75M | 19.10% |
| Dec 31, 2024 | 153.43M | 25.91% |
| Dec 29, 2023 | 121.86M | 75.67% |
| Dec 30, 2022 | 69.37M | -29.11% |
| Dec 31, 2021 | 97.86M | 59.23% |
| Dec 31, 2020 | 61.46M | 38.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 415.24M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 351.67M |
| CytoDyn | 341.59M |